221 related articles for article (PubMed ID: 24599673)
1. The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.
Shi S; Qin L; Tian M; Xie M; Li X; Qi C; Yi X
Tumour Biol; 2014 Jun; 35(6):5797-804. PubMed ID: 24599673
[TBL] [Abstract][Full Text] [Related]
2. Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.
Kamali M; Hamadani S; Neamatzadeh H; Mazaheri M; Zare Shehneh M; Modaress Gilani M; Haghighi F
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1743-1749. PubMed ID: 28749098
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk.
Yuan C; Liu X; Li R; Yan S; Kong B
Arch Med Sci; 2020; 16(3):682-691. PubMed ID: 32399118
[TBL] [Abstract][Full Text] [Related]
4. Association of RAD51 and XRCC2 Gene Polymorphisms with Cervical Cancer Risk in the Bangladeshi Women.
Ivy SC; Shabnaz S; Shahriar M; Jafrin S; Aka TD; Aziz MA; Islam MS
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2099-2107. PubMed ID: 34319032
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variations of RAD51 and XRCC2 Genes Increase the Risk of Colorectal Cancer in Bangladeshi Population.
Hridy AU; Shabnaz S; Asaduzzaman MD; Shahriar M; Bhuiyan MA; Islam MS; Hossen SMM; Emran TB
Asian Pac J Cancer Prev; 2020 May; 21(5):1445-1451. PubMed ID: 32458654
[TBL] [Abstract][Full Text] [Related]
6. Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study.
Gowtham Kumar G; Paul SFD; Martin J; Manickavasagam M; Sundersingh S; Ganesan N; Ramya R; Usha Rani G; Andrea Mary F
Mol Biol Rep; 2021 May; 48(5):4209-4220. PubMed ID: 34097201
[TBL] [Abstract][Full Text] [Related]
7. Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer.
Zhang W; Zhang Z
Oncotarget; 2016 Dec; 7(52):86621-86629. PubMed ID: 27863412
[TBL] [Abstract][Full Text] [Related]
8. XPG Asp1104His, XRCC2 Rs3218536 A/G and RAD51 135G/C Gene Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis.
Eskandari E; Rezaifar A; Hashemi M
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1805-1813. PubMed ID: 28749109
[TBL] [Abstract][Full Text] [Related]
9. Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis.
Kong F; Wu J; Hu L; Du Y; Pan Y
Int J Clin Exp Med; 2015; 8(4):6412-9. PubMed ID: 26131267
[TBL] [Abstract][Full Text] [Related]
10. Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.
Zeng X; Zhang Y; Yang L; Xu H; Zhang T; An R; Zhu K
Medicine (Baltimore); 2018 Jun; 97(26):e11251. PubMed ID: 29952992
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study.
Krupa R; Sliwinski T; Wisniewska-Jarosinska M; Chojnacki J; Wasylecka M; Dziki L; Morawiec J; Blasiak J
Mol Biol Rep; 2011 Apr; 38(4):2849-54. PubMed ID: 21104022
[TBL] [Abstract][Full Text] [Related]
13. An increased risk of ovarian cancer associated with polymorphism in BRCC5 gene in Caucasian populations.
Liang H; Li Y; Luo RY; Shen FJ
Tumour Biol; 2014 Sep; 35(9):9179-84. PubMed ID: 24927671
[TBL] [Abstract][Full Text] [Related]
14. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
[TBL] [Abstract][Full Text] [Related]
15. Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.
Zhang BB; Wang DG; Xuan C; Sun GL; Deng KF
Fam Cancer; 2014 Dec; 13(4):515-26. PubMed ID: 24859942
[TBL] [Abstract][Full Text] [Related]
16. RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.
Yu KD; Yang C; Fan L; Chen AX; Shao ZM
Breast Cancer Res Treat; 2011 Apr; 126(2):365-71. PubMed ID: 20461453
[TBL] [Abstract][Full Text] [Related]
17. RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis.
Cheng D; Shi H; Zhang K; Yi L; Zhen G
Diagn Pathol; 2014 Jan; 9():18. PubMed ID: 24457040
[TBL] [Abstract][Full Text] [Related]
18. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
[TBL] [Abstract][Full Text] [Related]
19. Relationship between interleukin-10 -1082A/G polymorphism and risk of ischemic stroke: a meta-analysis.
Jin J; Li W; Peng L; Chen J; Li R; Wu P; Tan S
PLoS One; 2014; 9(4):e94631. PubMed ID: 24732312
[TBL] [Abstract][Full Text] [Related]
20. Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis.
Hu S; Jing Y; Liu F; Han F
Biomed Res Int; 2022; 2022():3915402. PubMed ID: 35978646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
